NAM CROs & testing servicesconfirmed
PathoQuest
NGS-based viral safety testing for biologics, replacing animal-based adventitious agent tests.
Related deals
- Jan 2026M&ACharles River exercised its option to buy NGS viral safety firm PathoQuest to expand in vitro QC testing.Undisclosed; Charles River already held about 21%ir.criver.com(opens in new tab)
Related updates
No related news yet.